However, given HIF-1α’s substantial influence on the expression of genes linked to the development of cancer and the inadequate effectiveness of chemotherapy, the future direction will be to create pharmaceuticals that target HIF-1 with more specificity by elucidating the molecular architecture of the structural domains that mediate HIF-1α’s critical activities. Here, HIF1A is linked to cancer.